- Home
- LMFA vs ONVO Comparison
LMFA vs ONVO Comparison
Compare LMFA & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- ONVO
- Stock Information
- Founded
- LMFA 2008
- ONVO 2007
- Country
- LMFA United States
- ONVO United States
- Employees
- LMFA N/A
- ONVO N/A
- Industry
- LMFA Finance: Consumer Services
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LMFA Finance
- ONVO Health Care
- Exchange
- LMFA Nasdaq
- ONVO Nasdaq
- Market Cap
- LMFA 7.0M
- ONVO 7.2M
- IPO Year
- LMFA 2015
- ONVO N/A
- Fundamental
- Price
- LMFA $2.65
- ONVO $0.42
- Analyst Decision
- LMFA Hold
- ONVO
- Analyst Count
- LMFA 1
- ONVO 0
- Target Price
- LMFA N/A
- ONVO N/A
- AVG Volume (30 Days)
- LMFA 243.4K
- ONVO 102.4K
- Earning Date
- LMFA 11-13-2024
- ONVO 11-26-2024
- Dividend Yield
- LMFA N/A
- ONVO N/A
- EPS Growth
- LMFA N/A
- ONVO N/A
- EPS
- LMFA N/A
- ONVO N/A
- Revenue
- LMFA $12,838,084.00
- ONVO $103,000.00
- Revenue This Year
- LMFA N/A
- ONVO $59.08
- Revenue Next Year
- LMFA N/A
- ONVO $18.24
- P/E Ratio
- LMFA N/A
- ONVO N/A
- Revenue Growth
- LMFA 28.97
- ONVO N/A
- 52 Week Low
- LMFA $1.63
- ONVO $0.32
- 52 Week High
- LMFA $6.11
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- LMFA 44.64
- ONVO 47.62
- Support Level
- LMFA $2.99
- ONVO $0.39
- Resistance Level
- LMFA $4.38
- ONVO $0.46
- Average True Range (ATR)
- LMFA 0.45
- ONVO 0.05
- MACD
- LMFA -0.03
- ONVO -0.00
- Stochastic Oscillator
- LMFA 9.90
- ONVO 62.27
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.